Harmony Biosciences Holdings Inc (HRMY)
28.93
-0.30
(-1.03%)
USD |
NASDAQ |
Apr 25, 16:00
29.01
+0.08
(+0.28%)
After-Hours: 20:00
Harmony Biosciences Holdings Price to Book Value: 3.517 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.517 |
| April 24, 2024 | 3.553 |
| April 23, 2024 | 3.507 |
| April 22, 2024 | 3.568 |
| April 19, 2024 | 3.574 |
| April 18, 2024 | 3.529 |
| April 17, 2024 | 3.548 |
| April 16, 2024 | 3.620 |
| April 15, 2024 | 3.588 |
| April 12, 2024 | 3.586 |
| April 11, 2024 | 3.800 |
| April 10, 2024 | 3.570 |
| April 09, 2024 | 3.751 |
| April 08, 2024 | 3.628 |
| April 05, 2024 | 3.726 |
| April 04, 2024 | 3.796 |
| April 03, 2024 | 3.854 |
| April 02, 2024 | 3.975 |
| April 01, 2024 | 4.013 |
| March 28, 2024 | 4.082 |
| March 27, 2024 | 4.075 |
| March 26, 2024 | 3.892 |
| March 25, 2024 | 3.963 |
| March 22, 2024 | 4.049 |
| March 21, 2024 | 4.078 |
| Date | Value |
|---|---|
| March 20, 2024 | 4.09 |
| March 19, 2024 | 3.930 |
| March 18, 2024 | 3.840 |
| March 15, 2024 | 3.888 |
| March 14, 2024 | 3.812 |
| March 13, 2024 | 3.638 |
| March 12, 2024 | 3.698 |
| March 11, 2024 | 3.742 |
| March 08, 2024 | 3.779 |
| March 07, 2024 | 3.773 |
| March 06, 2024 | 3.730 |
| March 05, 2024 | 3.738 |
| March 04, 2024 | 3.753 |
| March 01, 2024 | 3.903 |
| February 29, 2024 | 3.902 |
| February 28, 2024 | 4.043 |
| February 27, 2024 | 4.070 |
| February 26, 2024 | 3.947 |
| February 23, 2024 | 3.951 |
| February 22, 2024 | 3.823 |
| February 21, 2024 | 4.012 |
| February 20, 2024 | 4.014 |
| February 16, 2024 | 4.110 |
| February 15, 2024 | 4.262 |
| February 14, 2024 | 4.120 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.336
Minimum
Oct 27 2023
30.89
Maximum
Nov 10 2020
11.28
Average
11.43
Median
Price to Book Value Benchmarks
| Amylyx Pharmaceuticals Inc | 0.2784 |
| Exelixis Inc | 3.151 |
| Insmed Inc | -- |
| Arcturus Therapeutics Holdings Inc | 2.529 |
| Ultragenyx Pharmaceutical Inc | 13.11 |
Price to Book Value Related Metrics
| PE Ratio | 13.65 |
| PS Ratio | 3.000 |
| Price to Free Cash Flow | 7.971 |
| Price | 28.93 |
| Earnings Yield | 7.33% |
| Market Cap | 1.642B |
| Operating PE Ratio | 9.094 |
| Normalized PE Ratio | 12.92 |